Danae is born: Innovation against bladder cancer
Discover how our clinical trials and research projects are improving our diagnostic systems for bladder cancer. Stay up to date with the latest news and publications related to our collaboration with scientific institutions and hospitals.
Generating new biomarkers for bladder cancer prognosis is crucial for advancing personalized medicine. At Danae Urogenomics, we are committed to continuous innovation in our diagnostic systems to ensure accuracy in the diagnosis and monitoring of this disease. Our clinical studies and research projects allow us to offer increasingly effective solutions. On our blog, we will share relevant news and publications about our scientific advances and collaborations. Follow us to stay up-to-date on the latest developments in the field of urogenital oncology!
